Viridos logo — See how algae moves us.

Viridos

See how algae moves us.

Founded 2005 United States La Jolla, United States 53 employees Series A Biotechnology, Health Care +1

General Information

Company Name Viridos
Founded Year 2005
Location United States La Jolla, United States
Founders / Decision Makers
Team member
Employees 53
Industries Biotechnology, Health Care, Renewable Energy
Funding Stage Series A
Social

Get notified when Viridos moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Viridos

Viridos, founded in 2005 and headquartered in the United States, stands as a pioneering force in biotechnology with a unique focus on renewable energy solutions. Under the slogan, "See how algae moves us," the company is leveraging its expertise in algal genetics to combat climate change.

The company's core mission is to harness photosynthesis, presenting a scalable platform for producing low-carbon biofuels specifically designed for aviation, commercial trucking, and maritime shipping. This strategic approach positions Viridos within the crucial intersection of Biotechnology, Health Care, and Renewable Energy industries, offering vast potential for growth in the expanding bioeconomy sector.

Their recent Series A investment on 13 March 2023, led by Breakthrough Energy Ventures and Chevron, validates the scalable promise of their innovative solutions. By turning lab-driven innovation into field-ready applications, Viridos exemplifies a high-impact investment opportunity within the green technology landscape.

Taxonomy: Algae Biofuels, Synthetic Biology, Photosynthesis, Genomic Solutions, Bioenergy Applications, Low-Carbon Intensity Fuels, Microbial Cultivation, Metabolic Engineering, Carbon Sequestration, Environmental Remediation, Advanced Biofuels, Bioprocessing, Gene Editing, Cell Engineering

Services & Products

Algae Biofuel Production
Renewable Energy Solutions
Biotechnology Development

Target Customers

Heavy Transportation Industries Environmental Organizations Renewable Energy Sector

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 2
Investor
•••• ••••
13 Mar 2023
Grant •••••• 1 •••• •••• 26 Jan 2023
Grant •••••• 1 •••• •••• 28 Apr 2022
Corporate Round •••••• 1 •••• •••• 22 Sep 2015
Corporate Round •••••• 1 •••• •••• 01 Apr 2014

View All 10 Funding Rounds

Viridos Alternatives & Competitors

Viridos vs
Xap Therapeutics
Xap Therapeutics United Kingdom

Nature gave us the parts. We provide the blueprints.

Series Unknown
34 employees
Biotechnology, Health Care
Viridos vs

Pioneering synthetic biology to engineer CAR‑T cells for immunotherapy.

2 employees
Viridos vs
Quell Therapeutics
Quell Therapeutics United Kingdom

Transformational Therapies, Transforming Lives

Series B
149 employees

FAQ About Viridos

See how algae moves us.
Viridos was founded in 2005.
Viridos is headquartered in La Jolla, United States.
Viridos operates in the following industries: Biotechnology, Health Care, Renewable Energy.
Viridos has approximately 53 employees.
Viridos has completed 10 funding rounds. The latest funding stage is Series A.
Viridos offers: Algae Biofuel Production, Renewable Energy Solutions, Biotechnology Development.
Top alternatives and competitors to Viridos include Xap Therapeutics, MY GENE AND CELL THERAPIES, Quell Therapeutics, Wanbang Biopharmaceuticals Co. Ltd, MarraBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Viridos and Xap Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Viridos and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy